当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:192.35亿  总市值:192.42亿
流通股本:11.58亿   总股本:11.58亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,737,971,817.287,904,152,454.145,798,660,551.633,905,925,550.52
  收到的税费返还99,466,050.03369,467,740.48304,318,738.35139,558,274.03
  收到其他与经营活动有关的现金38,124,665.53270,785,586.97190,903,061.3382,923,248.67
  经营活动现金流入小计1,875,562,532.848,544,405,781.596,293,882,351.314,128,407,073.22
  购买商品、接受劳务支付的现金1,028,481,894.45,147,723,410.543,824,738,181.962,507,807,853.95
  支付给职工以及为职工支付的现金350,619,906.11986,577,353.54710,162,856.09525,337,963.25
  支付的各项税费215,422,531.49481,977,236.19402,637,442.7303,868,594.79
  支付其他与经营活动有关的现金156,065,558.57707,926,500.57582,319,763.89384,212,100.91
  经营活动现金流出小计1,750,589,890.577,324,204,500.845,519,858,244.643,721,226,512.9
  经营活动产生的现金流量净额124,972,642.271,220,201,280.75774,024,106.67407,180,560.32
二、投资活动产生的现金流量:
  收回投资收到的现金1,057,022,526.721,238,929,600.55943,187,974.61502,027,895.5
  取得投资收益收到的现金-10,468,676.8910,468,676.8910,468,676.89
  处置固定资产、无形资产和其他长期资产收回的现金净额-33,027,522.952,354,172.451,437,975.94
  处置子公司及其他营业单位收到的现金净额-30,177,588.0230,054,923.3330,054,923.33
  收到的其他与投资活动有关的现金-266,572.74265,160.64-
  投资活动现金流入小计1,057,022,526.721,312,869,961.15986,330,907.92543,989,471.66
  购建固定资产、无形资产和其他长期资产支付的现金109,428,231.2386,214,539.82219,483,024.29165,748,763.93
  投资支付的现金1,062,111,4001,298,545,5001,004,745,500506,847,900
  支付其他与投资活动有关的现金-427,910.98427,910.98136,560
  投资活动现金流出小计1,171,539,631.21,685,187,950.81,224,656,435.27672,733,223.93
  投资活动产生的现金流量净额-114,517,104.48-372,317,989.65-238,325,527.35-128,743,752.27
三、筹资活动产生的现金流量:
  取得借款收到的现金240,000,0002,134,900,0001,620,900,0001,062,900,000
  筹资活动现金流入小计240,000,0002,134,900,0001,620,900,0001,062,900,000
  偿还债务支付的现金188,000,0001,416,000,0001,164,000,000673,000,000
  分配股利、利润或偿付利息支付的现金8,957,136.08836,106,817.82836,012,075.14428,077,335.27
  支付其他与筹资活动有关的现金29,336,574.67525,879,626.33190,673,547.93182,481,791.38
  筹资活动现金流出小计226,293,710.752,777,986,444.152,190,685,623.071,283,559,126.65
  筹资活动产生的现金流量净额13,706,289.25-643,086,444.15-569,785,623.07-220,659,126.65
四、汇率变动对现金及现金等价物的影响-16,375,254.92-9,951,342.783,355,523.377,432,261.76
五、现金及现金等价物净增加额7,786,572.12194,845,504.17-30,731,520.3865,209,943.16
  加:期初现金及现金等价物余额2,924,290,064.232,729,444,560.062,729,444,560.062,729,444,560.06
  期末现金及现金等价物余额2,932,076,636.352,924,290,064.232,698,713,039.682,794,654,503.22
补充资料:
  净利润-890,681,701.93-563,071,412.09
  资产减值准备-83,431,190.26-23,620,350.55
  固定资产和投资性房地产折旧-652,302,409.38-316,106,648.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-652,302,409.38-316,106,648.1
  无形资产摊销-10,082,544.47-5,769,821.05
  长期待摊费用摊销-9,085,712.96-3,554,724.68
  处置固定资产、无形资产和其他长期资产的损失--9,032,000.65--1,159,599.1
  固定资产报废损失-1,686,363.84-1,970,461.3
  公允价值变动损失---42,550.68
  财务费用-34,354,081.4--21,116,281.94
  投资损失--30,194,921.98--35,840,695.16
  递延所得税--24,321,718.92-2,339,587.79
  其中:递延所得税资产减少--7,038,549.9-10,607,927.42
    递延所得税负债增加--17,283,169.02--8,268,339.63
  存货的减少-165,584,111.48-166,191,966.2
  经营性应收项目的减少--227,868,060.56--78,948,649.83
  经营性应付项目的增加--342,738,844.61--541,765,743.78
  其他-525,492.83--
  现金的期末余额-2,924,290,064.23-2,794,654,503.22
  减:现金的期初余额-2,729,444,560.06-2,729,444,560.06
  现金及现金等价物的净增加额-194,845,504.17-65,209,943.16
公告日期2026-04-212026-03-202025-10-222025-08-20
审计意见(境内)标准无保留意见
TOP↑